Catis. Inc. (KOSDAQ:140430)
795.00
-25.00 (-3.05%)
At close: Apr 24, 2026
Catis. Revenue
In the year 2025, Catis. had annual revenue of 27.90B KRW, down -11.91%. Catis. had revenue of 9.37B in the quarter ending December 31, 2025, a decrease of -33.35%.
Revenue
27.90B
Revenue Growth
-11.91%
P/S Ratio
1.52
Revenue / Employee
593.65M
Employees
47
Market Cap
42.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.90B | -3.77B | -11.91% |
| Dec 31, 2024 | 31.67B | 1.66B | 5.52% |
| Dec 31, 2023 | 30.02B | -727.12M | -2.37% |
| Dec 31, 2022 | 30.74B | 9.32B | 43.51% |
| Dec 31, 2021 | 21.42B | 7.83B | 57.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| C-SITE | 169.72B |
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 103.26B |
| New Kids On | 49.03B |
| ADforus | 30.60B |
| Cellromax Science | 22.18B |
| MFC Co., Ltd. | 20.80B |
| Parataxis Ethereum | 14.00B |